GlassScriptPhysician profile
David R Bryant
NPI 1013984236
$418.02
in general payments reported to CMS, 2019-2025
16 companies · $48.89 in 2025
The $48.89 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.76 · 2020: $19.85 · 2021: $36.45 · 2022: $49.67 · 2023: $68.60 · 2024: $136 · 2025: $48.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $97.61 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $34.01 | 2024 | Dificid, Recarbrio, Zerbaxa |
| Bayer Healthcare Pharmaceuticals INC. | $33.16 | 2022 | |
| Ardelyx, INC. | $32.75 | 2023 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $29.96 | 2023-2024 | Entyvio |
| Qol Medical, LLC | $21.30 | 2024 | Sucraid |
| Dexcom, INC. | $20.78 | 2021 | |
| Intercept Pharmaceuticals, INC. | $19.57 | 2023 | Ocaliva |
| Sequel Med Tech, LLC | $18.15 | 2025 | Twiist |
| Novo Nordisk INC | $17.07 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.83 | 2025 | Lifevest |
| Urovant Sciences INC | $16.51 | 2022 | |
| Akcea Therapeutics, INC. | $15.67 | 2021 | |
| Janssen Biotech, INC. | $15.49 | 2024 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.25 | 2024 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.